Woolson Daniel
VP, GM-Infusion Capital
Woolson Daniel has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Woolson Daniel is listed as VP, GM-Infusion Capital at ICU MEDICAL INC/DE. Inside the rolling window, Woolson Daniel reported no open-market purchases and 3 open-market sales totaling $1.7M in ICUI. The largest disclosed transaction in the window is a sale of 5,417 ICUI shares on Aug 13, 2026, worth $982K.
Companies traded
Other insiders at ICUI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Woolson Daniel made?
Woolson Daniel has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Woolson Daniel trade?
Woolson Daniel has filed SEC Form 4 disclosures for 1 company, including ICUI.
When was Woolson Daniel's most recent SEC Form 4 filing?
Woolson Daniel's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Woolson Daniel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Woolson Daniel is listed as VP, GM-Infusion Capital.
What is Woolson Daniel's total buy and sell value in the current window?
Inside the rolling retention window, Woolson Daniel bought $0 and sold $1.7M based on SEC Form 4 filings.
What was Woolson Daniel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,417 ICUI shares on 2026-08-13, worth $982K, per SEC Form 4 filings.